Evidence map›Paper›PMID 18781985›Full record

ReviewCurrent pharmaceutical design2008

Role of cannabinoids and endocannabinoids in cerebral ischemia.

Cecilia J Hillard

Open access · greenAbstract readReview
In one paragraph

Review in Current pharmaceutical design, 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 45 papers.

0numbers the graph read from it
0cells of the map it votes in
45citing papers in PubMed
5.1field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

45 citing papers in PubMed, 110 citations in OpenAlex.

  1. Review
  2. Potential of CBD Acting on Cannabinoid Receptors CBInternational journal of molecular sciences · 2024
    Review
  3. Review
  4. Review
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Review
  14. Article
  15. Article
  16. Methanolic leaf extract ofIranian journal of basic medical sciences · 2019
    Article
  17. Review
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author at 1 institution in 1 country.

Cecilia J HillardDepartment of Pharmacology and Toxicology, Medical College of Wisconsin; Milwaukee, WI 53226, USA. chillard@mcw.edu
Medical College of Wisconsin · US

Funding

BIOCHEMISTRY OF ANANDAMIDE, AN ENDOGENOUS CANNABINOIDR01DA009155 · NIDA · MEDICAL COLLEGE OF WISCONSIN · PI HILLARD, CECILIA J · 1996 to 2011
$3.4M
NIDA NIH HHS DA09155NIDA NIH HHS R01 DA009155
6 · The paper itself

Abstract

The human costs of stroke are very large and growing; it is the third largest cause of death in the United States and survivors are often faced with loss of ability to function independently. There is a large need for therapeutic approaches that act to protect neurons from the injury produced by ischemia and reperfusion. The goal of this review is to introduce and discuss the available data that endogenous cannabinoid signaling is altered during ischemia and that it contributes to the consequences of ischemia-induced injury. Overall, the available data suggest that inhibition of CB1 receptor activation together with increased CB2 receptor activation produces beneficial effects.

Indexed as

EndocannabinoidsAnimalsBrain IschemiaCannabinoid Receptor ModulatorsCannabinoidsHumansNeuronsReceptor, Cannabinoid, CB1Receptor, Cannabinoid, CB2Reperfusion InjurySignal TransductionStrokeUnited StatesCannabinoid Receptor ModulatorsCannabinoidsEndocannabinoidsReceptor, Cannabinoid, CB1Receptor, Cannabinoid, CB2

Identifiers

PMID18781985
PMCPMC2581413
OpenAlexW2146020813

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.